9 terminated. 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Terminated 9 |
Follow ziprasidone: new trials by email Literature Review of ziprasidone trials Research Report on ziprasidone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder Ziprasidone, Placebo - Bipolar Disorder | Phase 3 | Terminated | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 23 | 2018-12-21 | 2021-06-16 |
| Pharmacovigilance in Gerontopsychiatric Patients Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression | Phase 3 | Terminated | Hannover Medical School | 407 | 2015-01-01 | 2018-02-28 |
| Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder placebo oral capsules, ziprasidone oral capsules - Bipolar Disorder | Phase 3 | Terminated | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 171 | 2014-05-23 | 2021-06-16 |
| One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome Ziprasidone HCL (oral) - Bipolar Disorder | Phase 3 | Terminated | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 13 | 2010-07-01 | 2021-03-03 |
| Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia Ziprasidone oral capsules - Schizophrenia | Phase 3 | Terminated | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 221 | 2006-06-01 | 2021-03-03 |
| Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia placebo, Ziprasidone oral capsules - Schizophrenia | Phase 3 | Terminated | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 284 | 2006-04-01 | 2021-03-25 |
| Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes aripiprazole (Abilify), ziprasidone (Geodon) - Schizophrenia, Schizoaffective Disorder | Phase 3 | Terminated | Northwestern University | 48 | 2006-01-01 | 2025-10-02 |
| A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder Ziprasidone - Schizophrenia, Schizoaffective Disorder | Phase 3 | Terminated | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 | 2004-09-01 | 2021-02-21 |
| A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic Schizophrenia Ziprasidone, Risperidone - Schizophrenia | Phase 3 | Terminated | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 240 | 2003-06-01 | 2021-02-21 |
Schizophrenia (6) · Bipolar Disorder (4) · Metabolic Syndrome (2) · Psychotic Disorders (2) · Anxiety Disorders (1) · Dementia (1) · Depression (1) · Psychophysiologic Disorders (1)
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (7) · Hannover Medical School (1) · Northwestern University (1)
United States (5) · Ukraine (3) · Colombia (2) · Costa Rica (2) · India (2) · Malaysia (2) · Peru (2) · Russia (2) · Singapore (2) · Canada (1) · Germany (1) · Portugal (1) · Spain (1)
Helge Frieling, Prof., MD (1) · Tianlai Tang, M.D. (1)